Company intelligence / Profile preview

WisdomTree

Ownership: Private
Employees: ~275
Development stage: Other

Overview

WisdomTree is a leading global asset management firm specializing in exchange-traded funds (ETFs) and exchange-traded products (ETPs), including thematic funds like the BioRevolution Fund. The BioRevolution Fund provides exposure to innovative biotechnology and life sciences companies driving advancements in genetics, gene editing, biomanufacturing, agriculture biotech, and related fields. The fund tracks indices designed to capture growth opportunities from transformative trends in biology technology.

Industry: Investors

Partnerships

Dr. Jamie Metzl

Beyond the preview

Go deeper on WisdomTree.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WisdomTree.

Explore the full profile